References
- Jabs D A, Enger C, Bartlett J G. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol 1989; 107: 75–80
- Holland G N, Prepose J S, Pettit T H, Gottlieb M S, Yee R D, Foos R Y. Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology 1983; 90: 859–873
- Collaborative DHPG Treatment Study Group. Treatment of serious cytomegalovirus infections with 9‐(2‐hydroxy‐1(hydroxymethyl)ethoxymethyl) guanine. Ann Intern Med 1985; 103: 323–327
- Laskin L K, Cederberg D M, Mills J, Eron L J, Milduan D, Spector S A. Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. Am J Med 1987; 83: 201–207
- Weisenthal I RW, Sinclair S H, Frank I, Rubin D H. Long term outpatient treatment of CMV retinitis with ganciclovir in AIDS patients. Br J Ophthalmol 1989; 73: 996–1001
- Henderly D E, Freeman W R, Causey D M, Rao N A. Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology 1987; 94: 425–432
- Buhles W C, Mastre B J, Tinter A J, Strand V, Koretz S H, The Syntex Collaborative Ganciclovir Study Group. Ganciclovir treatment of life or sight threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Rev Infect Dis 1988; 10(Suppl 3)495–506
- Matthew T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988; 10(Suppl 3)490–494
- Bloom J N, Palestine A G. The diagnosis of CMV retinitis. Ann Intern Med 1988; 109: 963–969
- Jacobsen M A, O'Donnell J J, Brodie H R, Wofsy C, Mills J. Randomized prospective trial of ganciclovir maintenance therapy for CMV retinitis. J Med Virol 1988; 25: 339–349
- Jennens I D, Lucas C R, Sandland A M, Maclean H, Hayes K. Cytomegalovirus cultures during maintenance DHPG therapy for cytomegalovirus retinitis in acquired immunodeficiency syndrome. J Med Virol 1990; 30: 42–44
- Centers for Disease Control. Revision of CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1985; 36(15)1–15
- Crowe S M, Carlin J B, Stewart K I, Lucas C R, Hoy J F. The predictive value of CD4 lymphocyte numbers for development of opportunistic infections and malignancies in HIV‐infected persons, In preparation
- Syntex, unpublished data. (CL 4197)